Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Indivior
Indivior
As it fights looming competition on Suboxone, Indivior gets FDA OK on new schizophrenia drug
Endpoints
Mon, 07/30/18 - 11:24 am
Indivior
FDA
Perseris
schizophrenia
Suboxone
Indivior's shares soar 33 percent after U.S. court blocks sale of rival generic
Reuters
Mon, 07/16/18 - 10:26 pm
Indivior
opioid addiction
generics
Suboxone Film
Dr Reddy's
Indivior shares dive after Dr Reddy's gets FDA approval for generic
Reuters
Fri, 06/15/18 - 09:49 pm
Indivior
FDA
generics
Suboxone Film
opioids
opioid addiction
Indivior Files Complaints Asserting New Suboxone Film Patent Against ANDA-Filers
Thu, 04/5/18 - 09:21 am
Suboxone Film
opioid addiction
Indivior
In a blow to its biggest revenue driver, Indivior loses patent battle with generics maker Alvogen
Endpoints
Fri, 03/23/18 - 09:52 am
Indivior
patents
Suboxone
Alvogen
generics
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
Endpoints
Thu, 03/22/18 - 09:21 am
drug launches
Hemlibra
Roche
Biktarvy
Gilead Sciences
Ozempic
Novo Nordisk
Erleada
JNJ
Shingrix
GSK
Patisiran
Alnylam
Sanofi
Epidiolex
GW Pharma
Aimovig
Amgen
Novartis
lanadelumab
Shire
Elagolix
AbbVie
Steglatro
Pfizer
Merck
Sublocade
Indivior
FDA panel votes yes on Indivior’s opioid addiction drug
Endpoints
Wed, 11/1/17 - 09:51 am
FDA
advisory panels
Indivior
opioid addiction
RBP-6000
buprenorphine
Reckitt Benckiser spinout climbs after PhIII schizophrenia trial hits endpoints
Fierce Biotech
Wed, 05/6/15 - 07:13 pm
Reckitt Benckiser
schizophrenia
RBP-7000
Indivior
Indivior CEO looks beyond 2015 after troubled Reckitt pharma unit's spinoff
Fierce Pharma
Fri, 01/2/15 - 07:41 pm
Reckitt Benckiser
Indivior
Pages
« first
‹ previous
1
2